Ann: Half-Year Financial Report, page-19

These are the negatives that number crunchers will see:

* Trade and Other Receivables only $90K. That debunks the theory that a lot of invoicing is on long repayment terms. Still a lot had not been invoiced as at end of December
* Revenues are pretty much the same as cost of sales. To me this is reasonable in this early stage where fine tuning of product is still occurring before final product ramp up.

2016 is the year. If in doubt I just look at the requirements for directors to attain their performance shares. It sets the bar pretty high compared to most director performance shares I've ever seen before. Nevertheless share price will remain subdued for a little while yet.